Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Clinical trial NCT02556814 · COMPLETED

Trial details

NCT number: NCT02556814
Sponsor: Shandong University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2015-09-01
Primary completion: 2018-03-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.